USD 5.08 Billion
Diabetic Neuropathy Treatment Market Size, Share, Growth Analysis, By Drug Class(Non-steroidal Anti-inflammatory Drugs, Opioid, Anti-depressants, Anti-seizure), By Disease(Peripheral, Autonomic, Proximal, and Focal), By Distribution Channels(Hospitals, Clinics, Retail Pharmacies, and Online Pharmacies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2836 |
Region:
Global |
Published Date: April, 2024
Pages:
211
|Tables:
94
|Figures:
73
Diabetic Neuropathy Treatment Market Insights
Diabetic Neuropathy Treatment Market size was valued at USD 5.08 Billion in 2022 and is poised to grow from USD 5.53 Billion in 2023 to USD 10.94 Billion by 2031, growing at a CAGR of 8.9% in the forecast period (2024-2031).
Diabetic nephropathy is a disease that causes nerve damage in people with diabetes. High levels of sugar in the blood of diabetics causes nerve damage called diabetic neuropathy. This damages the nerves, especially in the legs and feet. Additionally, arthritis symptoms vary from pain to nausea depending on the affected nerves including peripheral, autonomic, proximal, and focal neuropathy. Additionally, peripheral neuropathy affects the legs and feet, autonomic neuropathy affects the digestive tract system and especially to abdomen, proximal. Rheumatoid arthritis can cause hip, hip and thigh pain and affected muscles can lead to numbness in the legs and feet, digestive disorders, fluid retention and heartburn.
The increasing prevalence of diabetes across the globe is the major driver for the diabetic neuropathy treatment market. As diabetes worsens, the incidence of diabetic neuropathy also increases, leading to a demand for treatment options. Older people are more likely to develop diabetes and its complications including arthritis. With the aging of the world population, there is an increasing demand for the treatment of diabetic neuropathy, driving the growth of the market. Ongoing R&D efforts have led to advanced treatments for diabetic neuropathy Technological advances such as new drug developments, medical devices, and regenerative medicines are driving the market has been improved to provide effective and efficient treatment solutions. Increased awareness of diabetes and its complications among healthcare providers and patients has led to earlier diagnosis of diabetic nephropathy. Early detection increases the number of patients seeking treatment, thereby boosting the market.
US Diabetic Neuropathy Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Peripheral
Fastest Growth
Autonomic
Growth Rate
8.9% CAGR
Global Diabetic Neuropathy Treatment Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Diabetic Neuropathy Treatment Market Segmental Analysis
In terms of drug class, the market is segmented into non-steroidal anti-inflammatory drugs, opioid, anti-depressants, anti-seizure, and others. Based on the disease, the market is segmented into peripheral, autonomic, proximal, and focal. Based on distribution channels the diabetic neuropathy treatment market is segmented into hospitals, clinics, retail pharmacies, and online pharmacies. Based on region the global diabetic neuropathy treatment market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.
Diabetic Neuropathy Treatment Market Analysis by Drug Class
Use of non-steroidal segment in the anti-inflammatory drugs across the globe. Increase in prescribing drugs containing non-steroidal anti-inflammatory drugs with high efficacy to treat the disorder driving the market growth high. This in turn encourages manufacturers to develop non-steroidal anti-inflammatory drugs, which is positively impacting the growth of the market non-steroidal anti-inflammatory drugs help in reducing pain, fever, etc. by the increased inflammation required for healing.
The opioid segment is expected to register a slightly higher CAGR during the forecast period, owing to the introduction of new gel formulations, rise in analgesics, among others. Also, antidepressants help reduce pain, problems with insomnia, etc. by increasing neurotransmitters in the brain.
Diabetic Neuropathy Treatment Market Analysis by Disease
The peripheral segment dominated the growth of the market, the high incidence of peripheral neuropathies worldwide. Diabetes mellitus occurs primarily in diabetic neurodegenerative disease populations. According to the National Center for Biotechnology Information, the prevalence of diabetes mellitus in adults is reported to range from 6% to 51% as it depends on a variety of factors including age, type of diabetes, glucose utilization and duration of diabetes.
Autonomic diabetic neuropathy is expected to exhibit the highest CAGR during the forecast period. Increased prevalence of diabetics in metropolitan areas increases the demand for safe and effective risk-free treatments as compared to galloping strategies enhancing market growth. Furthermore, the movement of diabetes higher due to increased adoption of sedentary lifestyles also spreads significant growth s of people with diabetes have been estimated and the number is expected by 2045 to increase to 629 million.
Global Diabetic Neuropathy Treatment Market By Disease (%)
To get detailed analysis on other segments, Request For Free Sample Report
Diabetic Neuropathy Treatment Market Regional Insights
North America is expected to be the major regional market due to the high, high incidence of diabetes. In addition to this, fast availability of pharmaceuticals, availability of advanced treatments in the industry, and availability of compounded drugs are also driving the growth of the market. According to the National Diabetes Report, it is estimated that the US. 26.9 million people have diabetes. North America holds the largest share in the global diabetic neuropathy treatment market. There is a well-established healthcare system, high healthcare costs, and many patients affected by diabetes and its complications, including arthritis, within the facility.
The market is expected to grow at the highest CAGR due to high prevalence of diabetes, rise in problems associated with obesity and heart failure in Asia-Pacific, increasing use of new advanced medicines, government support for increased health literacy, increased R&D activities, among others. Asia-Pacific accounts for a large portion of the global diabetic population, driven by factors such as urbanization, sedentary lifestyles and dietary changes While prevalence of diabetes in countries such as China, India and Japan, so too is the incidence of diabetic neuropathy, creating a huge market demand for treatment options.
Global Diabetic Neuropathy Treatment Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Diabetic Neuropathy Treatment Market Dynamics
Diabetic Neuropathy Treatment Market Drivers
Increasing Prevalence of Diabetes Across the Globe
- The prevalence of diabetes affects the growth of the global diabetic neuropathy treatment market during the forecast period. Moreover, vascular disease due to diabetes, heart disease, obesity and other challenges related to glucose utilization are considered as some of the factors driving the growth of the market along with consumption of unhealthy foods, sedentary lifestyle under poor quality of life due to increased urbanization also market development.
Advances in Personalized Medicine
- Personalized medicine, also known as precision medicine, is a key driver of the global diabetic neuropathy treatment market This approach for the treatment tailor it to each patient’s individual characteristics, including their genetics, lifestyle and environment. In recent years, there has been an increasing emphasis on personalized medicine in healthcare, driven by advances in genomics, biomarker identification and data analysis Through the course of specific genetic markers or biomarkers associated with diabetic neuropathy on and by identifying their response to treatment, health care providers can optimize treatment selection and dosage, leading to better symptom management and disease control Not a focus this in personalized medicine Not only improves the effectiveness of existing therapies but also drives innovation in the development of new therapies, driving growth in the global diabetic neuropathy treatment market.
Diabetic Neuropathy Treatment Market Restraints
High Medical Costs
- High-cost requirements for treatment modalities restrain market growth. Many marketers are investing heavily in creating new and improved treatment options to accelerate recovery and costs are increasing in the coverage range. New therapies, for example, cost between $314 million and $2.8 billion to develop, and the market will collapse over the forecast period.
Strict Regulatory Challenges and Approval Process
- Regulatory challenges and approvals are a major restriction in the global diabetic neuropathy treatment market. In the development and marketing of new drugs, medical devices, or treatments for diabetic neuropathy, complex regulatory mechanisms by regulators such as the Food and Drug Administration (FDA) of the United States and the European Medicines Agency (EMA) a is in European Directive established These regulatory frameworks require extensive clinical trials to establish safety, efficacy, and quality standards before approving a drug for market Requirements in which is difficult, lengthy, and high costs associated with regulatory compliance create barriers for medical biotech companies to enter Furthermore, delays in bringing new therapies to market, changes in regulatory guidelines internal or unexpected regulatory hurdles may further delay development and approval, affecting market growth and innovation in the treatment of diabetic neuropathy.
Request Free Customization of this report to help us to meet your business objectives.
Diabetic Neuropathy Treatment Market Competitive Landscape
The competitive environment of the Global Diabetic Neuropathy Treatment Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. The global diabetic neuropathy treatment market is characterized by fierce competition among pharmaceutical companies, medical device manufacturers, and biotechnology companies. Major players in the market keep growing their product lines, expanding the market presence, mergers and acquisitions, collaboration, product differentiation and gain competitive advantage through strategic initiatives.
Diabetic Neuropathy Treatment Market Top Player’s Company Profiles
- Eli Lilly and Company
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- GlaxoSmithKline Plc
- Lupin Ltd
- Depomed, Inc
- Astellas Pharma Inc
- Meda Pharma GmBH & Co. KG
- Pfizer Inc.
- Novo Nordisk A/S
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
Diabetic Neuropathy Treatment Market Recent Developments
- In March 2022, Yostra Labs, a medtech startup based in India, announced that the company, which raised US$484,164 in seed funding led by Vilgro Innovations Foundation, Indian Angel Network, and other investors, has some unique features management and diagnosis of peripheral neuropathy. The company was expected to use the capital to expand its staff and marketing teams.
- In January 2022, the FDA approved spinal stimulation for the treatment of chronic pain caused by diabetic neuropathy, according to Medtronic.
- In December 2023, Vertex Pharmaceuticals received FDA approval for CRISPR-based gene editing therapy, a strategy focused on developing and promoting non-opioid pain relievers Based on Vertex's Phase 2 clinical trial results for VX-548, highlighting alternative pain management strategies in diabetic peripheral neuropathy Thiah of the safe and consistent with the search for more effective treatments. This strategy ensures competitive advantage by addressing the urgent need for innovative solutions in the market.
- In July 2023, Indian pharmaceutical company Asprius Lifesciences recently started treating diabetic neuropathy, a disease that causes nerve damage in different parts of the body The company has filed patents for a patented drug combination (FDC), indicating potential for peripheral nerve block. These developments allow Asprius to establish a competitor in the global marketplace and meet the broader need for effective solutions.
Diabetic Neuropathy Treatment Key Market Trends
- Increasing Awareness of Diabetes Management: Worldwide, diabetes management is considered a priority. The increasing number of diabetics is driving the growth of this market. Also, increasing incidence of diabetic neuropathy, increasing awareness of diabetes management, and others motivate key players to focus on new product launches in coming years due to the acquisition of technologies by key players advanced for diabetic neuropathy advanced treatment market during the forecast period hence -focuses on product development. The manufacturers focus on producing transdermal patches, facial sprays and powders. For example, diabetes medications administered by aggressive methods, such as insulin, are more problematic to take on a daily basis.
Diabetic Neuropathy Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global diabetic neuropathy treatment market is experiencing tremendous growth driven by several key factors. The increasing prevalence of diabetes worldwide, especially in the elderly population, has increased the incidence of diabetic neuropathy, driving the market demand for more effective treatments Technological advances in personalized medicine has enabled more targeted and effective therapies, improved patient outcomes and expanding the market. However, the market faces challenges such as regulatory hurdles and stringent approval processes, which can delay the launch of new therapies and hamper market growth High medical costs also pose barrier types come to be excluded, especially in developing areas where health facilities are limited. Despite these challenges, the competitive environment in the global diabetic neuropathy treatment market remains intense, with leading pharmaceutical companies, medical device manufacturers and biotech companies competing for market share. Mergers and acquisitions, collaboration, product differentiation and other strategic arrangements among specialists lead to product innovation and market competition.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.08 Billion |
| Market size value in 2031 | USD 10.94 Billion |
| Growth Rate | 8.9% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Diabetic Neuropathy Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Diabetic Neuropathy Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Diabetic Neuropathy Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Diabetic Neuropathy Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Diabetic Neuropathy Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Diabetic Neuropathy Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
